A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Ipratropium (Atrovent)

Anticholinergic class · 10 generic manufacturers · 16 ANDAs filed at FDA.

First FDA approval2001-09-27
Generic availableYes · 10 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$244.7M in CY2024 Part D spend3.6M claims · 1.6M beneficiaries · 329 plans surveyed

Lowest NADAC
$0.099/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.149
Across all dosage forms in distribution.
Highest NADAC
$0.405
Range is tight.
Plans with PA
335 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Ipratropium used for?

Ipratropium is a Anticholinergic medication tracked in Medicare Part D.

Is there a generic for Ipratropium?

Yes. 16 ANDAs filed at FDA, 10 generic manufacturers currently shipping.

How much does my plan pay for Ipratropium?

Across 329 Part D plans, Ipratropium averages $0.149/unit (NADAC). Lowest available: $0.099/unit. Highest in distribution: $0.405/unit.

Is Ipratropium on the FDA shortage list?

No. Ipratropium is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Anticholinergic6 alternatives in D1
01
Atropine
Brand: ATROPEN Auto-Injector
$4.33Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Atropine Injection,
Anticholinergic
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Atropine Sulfate Injection Usp,
Anticholinergic
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Benztropine
Anticholinergic
$0.067Lowest NADAC
12Generic mfrs
$35.4MCY24 Part D spend
Compare →
05
Glycopyrrolate
Brand: Cuvposa
$0.103Lowest NADAC
35Generic mfrs
$15.4MCY24 Part D spend
Compare →
06
Ipratropium and Albuterol
Brand: Combivent Respimat
$0.084Lowest NADAC
4Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.